Evidence map›Paper›PMID 36041745›Full record

ArticleBMJ (Clinical research ed.)2022

Patterns of tobacco use in low and middle income countries by tobacco product and sociodemographic characteristics: nationally representative survey data from 82 countries.

Michaela Theilmann, Julia M Lemp, Volker Winkler, Jennifer Manne-Goehler, Maja E Marcus, Charlotte Probst, William A Lopez-Arboleda, Cara Ebert, Christian Bommer, Maya Mathur and 15 more

Open access · hybridAbstract read
In one paragraph

Article in BMJ (Clinical research ed.), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 55 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
55citing papers in PubMed, 3 pooled it
8.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

55 citing papers in PubMed, 3 syntheses or guidelines pooled it, 80 citations in OpenAlex.

  1. Pooled it
  2. RuralEuropean respiratory review : an official journal of the European Respiratory Society · 2026
    Pooled it
  3. Pooled it
  4. Trial
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. The economic burden of lung cancer in low- and lower-middle-income countries: a systematic review.Archives of public health = Archives belges de sante publique · 2025
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

25 authors at 15 institutions in 12 countries.

Michaela TheilmannHeidelberg Institute of Global Health, Heidelberg University, Heidelberg, Germany.
Julia M LempHeidelberg Institute of Global Health, Heidelberg University, Heidelberg, Germany.
Volker WinklerHeidelberg Institute of Global Health, Heidelberg University, Heidelberg, Germany.
Jennifer Manne-GoehlerDivision of Infectious Diseases, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Maja E MarcusDepartment of Economics and Centre for Modern Indian Studies, University of Goettingen, Göttingen, Germany.
Charlotte ProbstHeidelberg Institute of Global Health, Heidelberg University, Heidelberg, Germany.
William A Lopez-ArboledaHeidelberg Institute of Global Health, Heidelberg University, Heidelberg, Germany.
Cara EbertRWI-Leibniz Institute for Economic Research, Essen (Berlin Office), Germany.
Christian BommerHeidelberg Institute of Global Health, Heidelberg University, Heidelberg, Germany.
Maya MathurQuantitative Sciences Unit and Department of Pediatrics, Stanford University, Stanford, CA, USA.
Glennis Andall-BreretonPort of Spain, Trinidad and Tobago.
Silver K BahendekaSt Francis Hospital, Kampala, Uganda.
Pascal BovetMinistry of Health, Victoria, Seychelles.
Farshad FarzadfarNon-Communicable Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.
Erfan GhasemiNon-Communicable Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.
Mary T MayigeNational Institute for Medical Research, Dar es Salaam, Tanzania.
Sahar Saeedi MoghaddamEndocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.
Kibachio J MwangiDivision of Non-Communicable Diseases, Ministry of Health, Nairobi, Kenya.
Shohreh NaderimaghamNon-Communicable Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.
Lela SturuaNon-Communicable Disease Department, National Center for Disease Control and Public Health, Tbilisi, Georgia.
Rifat AtunDepartment of Global Health and Population, Harvard TH Chan School of Public Health, Boston, MA, USA.
Justine I DaviesMRC/Wits Rural Public Health and Health Transitions Research Unit, School of Public Health, University of the Witwatersrand, Johannesburg, South Africa.
Till BärnighausenHeidelberg Institute of Global Health, Heidelberg University, Heidelberg, Germany.
Sebastian VollmerDepartment of Economics and Centre for Modern Indian Studies, University of Goettingen, Göttingen, Germany.
Pascal GeldsetzerDivision of Primary Care and Population Health, Stanford University, Stanford, CA, USA.ORCID 0000-0002-8878-5505
Heidelberg University · DETehran University of Medical Sciences · IRUniversity of Göttingen · DEBrigham and Women's Hospital · USCentre for Addiction and Mental Health · CACentre universitaire de médecine générale et santé publique, Lausanne · CHChan Zuckerberg Initiative (United States) · USHarvard University · USNaggalama Hospital · UGNational Center for Disease Control and Public Health · GENational Institute for Medical Research · TZRWI – Leibniz Institute for Economic Research · DEStanford University · USUniversity of Geneva · CHUniversity of the Witwatersrand · ZA

Funding

PROGRAM FOR AIDS CLINICAL RESEARCH TRAINING (PACRT)T32AI007433 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI MARK J SIEDNER · 1992 to 2026
$11.4M
NIAID NIH HHS T32 AI007433
6 · The paper itself

Abstract

objectivesTo determine the prevalence and frequency of using any tobacco product and each of a detailed set of tobacco products, how tobacco use and frequency of use vary across countries, world regions, and World Bank country income groups, and the socioeconomic and demographic gradients of tobacco use and frequency of use within countries.

designSecondary analysis of nationally representative, cross-sectional, household survey data from 82 low and middle income countries collected between 1 January 2015 and 31 December 2020.

settingPopulation based survey data.

participants1 231 068 individuals aged 15 years and older.

main outcome measuresSelf-reported current smoking, current daily smoking, current smokeless tobacco use, current daily smokeless tobacco use, pack years, and current use and use frequencies of each tobacco product. Products were any type of cigarette, manufactured cigarette, hand rolled cigarette, water pipe, cigar, oral snuff, nasal snuff, chewing tobacco, and betel nut (with and without tobacco).

resultsThe smoking prevalence in the study sample was 16.5% (95% confidence interval 16.1% to 16.9%) and ranged from 1.1% (0.9% to 1.3%) in Ghana to 50.6% (45.2% to 56.1%) in Kiribati. The user prevalence of smokeless tobacco was 7.7% (7.5% to 8.0%) and prevalence was highest in Papua New Guinea (daily user prevalence of 65.4% (63.3% to 67.5%)). Although variation was wide between countries and by tobacco product, for many low and middle income countries, the highest prevalence and cigarette smoking frequency was reported in men, those with lower education, less household wealth, living in rural areas, and higher age.

conclusionsBoth smoked and smokeless tobacco use and frequency of use vary widely across tobacco products in low and middle income countries. This study can inform the design and targeting of efforts to reduce tobacco use in low and middle income countries and serve as a benchmark for monitoring progress towards national and international goals.

Indexed as

Tobacco ProductsTobacco, SmokelessCross-Sectional StudiesDeveloping CountriesHumansMalePrevalence

Identifiers

PMID36041745
PMCPMC10471941
OpenAlexW4293577373

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.